Navigation Links
Pharmaceuticals Market Access Taiwan 2013

DUBLIN, June 5, 2013 /PRNewswire/ --

Research and Markets ( has announced the addition of a new report "Pharmaceuticals Market Access Taiwan" to their offering.


January 2013 will see implementation of Taiwan's second generation national health insurance law bringing important changes to the market for prescription medicines in one of Asia's booming tiger economies. The new drug pricing process will be modified and the importance of health technology assessment (HTA) reaffirmed. The Cross-Strait Co-operation Agreement on Medicine and Public Health Affairs with mainland China might be of even greater significance in the longer term as this potentially leads to progressive mutual recognition of clinical trial results. R&D companies active in Taiwan will then have easier access to the 1.3 billion consumers speaking the same language waiting just across the Strait.

Written with the understandable detail and objectivity you require, Pharmaceuticals Market Access Taiwan provides the answers needed for product introduction and life-cycle management in the sixth-largest market in Asia-Pacific:

- How the drug categorisation, launch pricing, price-volume agreement and price revision processes work, with data sources, timelines, examples and results.

- HTA policies by the Center for Drug Evaluation explained, with data sources, timelines, examples and results.

- Drug expenditure target as an alternative to biennial price cuts.

- Incomplete separation between prescribing and dispensing and the drug price gap.

- Impact of global budgets on pharmaceutical costs.

- Pay-for-performance incentives for prescribers.

- One of the world's best environments for rare disease management.

- Generic pricing and its relationship to product quality.

Key Features

Focusing on NHI reimbursement pricing but encompassing the IND to the PMS stages.

Over 30 tables, figures & case studies. Much not published in English before.

Based on face-to-face interviews with key market participants and data collection conducted in Taipei during September 2012. Includes brand-new local pharmacoeconomic study checklist.

Key Topics Covered:

Executive Summary

1. Market Introduction
2. Pharmaceutical Sector
3. Introductory Pricing of New Drugs
4. Health Technology Assessment
5. Price Revision
6. Generics
7. Demand-Side Controls
8. Payment of Providers
9. Distribution
10. Prospects for Change

List of Tables
List of Figures

Glossary of Abbreviations and Acronyms


Donald Macarthur

For more information visit

Source: Just Pharma Reports
Research and Markets
Laura Wood , Senior Manager.
U.S. Fax: +1-646-607-1907
Fax (outside U.S.): +353-1-481-1716

Sector: Pharmaceuticals

SOURCE Research and Markets
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Savient Pharmaceuticals to Hold First Quarter 2012 Financial Results Conference Call on Wednesday, May 9, 2012
2. Auxilium Pharmaceuticals to Present at the Deutsche Bank 37th Annual Healthcare Conference
3. Nouveau Life Pharmaceuticals (HRID) Contracts with U.S. Manufacturer to Produce New Female Supplement
4. BioElectronics Survey Indicates a Five-Fold Superior Pain Relief Compared to OTC Pharmaceuticals
5. Icahn Issues Statement Regarding Amylin Pharmaceuticals
6. Almost 50 Percent of the Glaucoma Patient Population Remains Untreated, Signifying a Vast Market for Glaucoma Pharmaceuticals, Finds Frost & Sullivan
7. Omthera Pharmaceuticals Announces Positive Top-Line Results from Phase 3 EVOLVE Study
8. Onyx Pharmaceuticals Announces FDA Advisory Committee to Review Carfilzomib for the Treatment of Patients with Relapsed and Refractory Multiple Myeloma
9. Jazz Pharmaceuticals Announces First Quarter 2012 Financial Results Conference Call On May 8, 2012
10. Inovio Pharmaceuticals Granted U.S. Patent Protection for Synthetic Vaccine for Cervical Dysplasia and Cancer
11. Avanir Pharmaceuticals To Present at Three Conferences In May
Post Your Comments:
(Date:6/24/2016)... 2016  Arkis BioSciences, a leading innovator in ... durable cerebrospinal fluid treatments, today announced it has ... is led by Innova Memphis, followed by Angel ... investors.  Arkis, new financing will accelerate the commercialization ... release of its in-licensed Endexo® technology. ...
(Date:6/23/2016)... DUBLIN , June 23, 2016 ... the "Pharmaceutical Excipients Market by Type (Organic Chemical ... Preservative), Formulation (Oral, Topical, Coating, Parenteral) - Global Forecast ... The global pharmaceutical excipients ... 2021 at a CAGR of 6.1% in the forecast ...
(Date:6/23/2016)... , June 23, 2016 ... CAPR ), a biotechnology company focused on the ... announced that patient enrollment in its ongoing randomized ... has exceeded 50% of its 24-patient target. Capricor ... the third quarter of 2016, and to report ...
Breaking Medicine Technology:
(Date:6/27/2016)... ... June 27, 2016 , ... recently awarded their highest five-star rating ... Millions of individuals in the United States and Canada wear eyeglasses. Once considered to ... correct vision and make a fashion statement. Even celebrities use glasses as a way ...
(Date:6/26/2016)... ... ... PawPaws brand pet supplements owned by Whole Health Supply is ... of felines. The formula is all-natural and is made from Chinese herbs that have ... Kidney Support Supplement Soft Chews are Astragalus Root Extract and Rehmannia Root Extract ...
(Date:6/25/2016)... TX (PRWEB) , ... June 25, 2016 , ... Austin ... of the American College of Mohs Surgery and to Dr. Russell Peckham for medical ... and highly effective treatment for skin cancer. The selective fellowship in Mohs Micrographic Surgery ...
(Date:6/25/2016)... ... , ... As a lifelong Southern Californian, Dr. Omkar Marathe earned his Bachelors ... Geffen School of Medicine at UCLA. He trained in Internal Medicine at Scripps Green ... hematology/oncology at the UCLA-Olive View-Cedars Sinai program where he had the opportunity to train ...
(Date:6/24/2016)... ... June 24, 2016 , ... A recent article ... are unfamiliar with. The article goes on to state that individuals are now more ... these less common operations such as calf and cheek reduction. The Los Angeles area ...
Breaking Medicine News(10 mins):